Patents by Inventor Shao-Cong Sun

Shao-Cong Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING OTUB1 IN IMMUNOTHERAPY
    Publication number: 20220233594
    Abstract: The present disclosure provides methods for generating Otub 1 deficient T cells and natural killer (NK) cells and compositions comprising engineered T cells expressing a reduced amount of Otub 1. Further provided are methods of treating cancer comprising administering the Otub 1 deficient T cells and/or NK cells to a subject in need thereof.
    Type: Application
    Filed: May 7, 2020
    Publication date: July 28, 2022
    Applicant: Board of Regents, The University of Texas System
    Inventors: Shao-Cong SUN, Xiaofei ZHOU
  • Nucleic acids encoding dominant negative I-&kgr;-B -&agr; polypeptides
    Patent number: 6180772
    Abstract: Methods and compositions for the inhibition of NF-&kgr;B activation are disclosed.
    Type: Grant
    Filed: April 22, 1998
    Date of Patent: January 30, 2001
    Assignee: J. David Gladstone Institutes
    Inventors: Warner C. Greene, Shao-Cong Sun, Parham Ganchi